The landscape of treatment for hereditary angioedema (HAE) has transformed rapidly in 2025, marked by the US Food and Drug Administration’s (FDA) approval of...
Dr. David Kessler, the former commissioner of the US Food and Drug Administration (FDA), has launched a significant challenge to the current administration’s commitment...